TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-25 06:07 am Sale | 2021-10-19 | 13G | Mirum Pharmaceuticals, Inc. MIRM | TAKEDA PHARMACEUTICAL CO LTD | 530,562 1.700% | -1,328,589 (-71.46%) | Filing |
| 2021-01-27 06:02 am Unchanged | 2020-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | TAKEDA PHARMACEUTICAL CO LTD | 1,859,151 7.200% | 0 (Unchanged) | Filing |